Zetonna Q1 quotas

Quote

Anonymous

Guest
Im toast. Now I finally see why reps always said not to blow out a launch. My quota is laughable and impossible. Preparing myself for a PIP or cut in Q2. And we thought 70% as a nation was bad. Grrrr. Sunovion leadership=clueless
 




































Are you new or just retarded?!

This is how this place works. Hero to zero. Plus how do you think they can afford to pay us selling 50,100, even 150 Zetonna. At what point do you think we break even with 80,90,100k salaries.

You are toast, naive toast


Anonymous said:
Im toast. Now I finally see why reps always said not to blow out a launch. My quota is laughable and impossible. Preparing myself for a PIP or cut in Q2. And we thought 70% as a nation was bad. Grrrr. Sunovion leadership=clueless
Click to expand...
 






It's hard to argue that fact that we won't be around for much longer. Too bad we didn't do a bit more market research on this product. Even QNASL is dead in the water with their huge sales force. No one wants or needs this drug. Doc's see no reason for it to be used. Our managed care coverege here in the NE sucks and I can't blame my AD for that. Hell, I can't get docs to even try it just imagine how difficult it must be to get a managed care plan to even look at it with 80% of the class already generic and Nasonex going generic in less than a year.
 






Anonymous said:
Im toast. Now I finally see why reps always said not to blow out a launch. My quota is laughable and impossible. Preparing myself for a PIP or cut in Q2. And we thought 70% as a nation was bad. Grrrr. Sunovion leadership=clueless
Click to expand...

This is pharma sales 101 for the last 5 years or so. NEVER EVER blow out a product launch. You will pay for it for years to come....if you make it past year 2 of the blowout year. Dummy!
 






Everyone is screwed - no matter if you blew it out in Q4 or finished at 20%~ which a lot did... They raised EVERYONE'S quotas 200+%- they are setting us up for failure ... Creating a "Summit situation"- they will put blame on us saying we didn't meet quota... They are seriously asking us to do now with Zetonna what we did with Omnaris 2 years after launch- there are already Omnaris - Xopenex HFA- contract reps in place- some already calling on our docs- they are being FAR from transparent with us- clearly doing away with respiratory... March or June- " my STAYABILITY is about 2-4 mo
 












Anonymous said:
It's hard to argue that fact that we won't be around for much longer. Too bad we didn't do a bit more market research on this product. Even QNASL is dead in the water with their huge sales force. No one wants or needs this drug. Doc's see no reason for it to be used. Our managed care coverege here in the NE sucks and I can't blame my AD for that. Hell, I can't get docs to even try it just imagine how difficult it must be to get a managed care plan to even look at it with 80% of the class already generic and Nasonex going generic in less than a year.
Click to expand...

Now don't get too down just yet. I'm hearing that we won't be at Sunovion much longer but I'm also hearing we and the entire allergy/asthma team will be sold off. I for one would welcome that. I know we'd have to go through being merged into another company and may be laid off but if we stay here with Zetonna doing NOTHING we're going to be gone anyway. You know it and I know it. Actually, anyone in the field trying to sell Zetonna knows it.

So I say I hope the rumor that we are going to be sold of and no longer part of Sunovion is true, true, true.
 












Anonymous said:
Now don't get too down just yet. I'm hearing that we won't be at Sunovion much longer but I'm also hearing we and the entire allergy/asthma team will be sold off. I for one would welcome that. I know we'd have to go through being merged into another company and may be laid off but if we stay here with Zetonna doing NOTHING we're going to be gone anyway. You know it and I know it. Actually, anyone in the field trying to sell Zetonna knows it.

So I say I hope the rumor that we are going to be sold of and no longer part of Sunovion is true, true, true.
Click to expand...

We couldn't sell this division if we paid someone to take it and threw in the dumbass marketing and sales VP with it. PS and JZ are to blame for this whole mess.
 






Anonymous said:
Now don't get too down just yet. I'm hearing that we won't be at Sunovion much longer but I'm also hearing we and the entire allergy/asthma team will be sold off. I for one would welcome that. I know we'd have to go through being merged into another company and may be laid off but if we stay here with Zetonna doing NOTHING we're going to be gone anyway. You know it and I know it. Actually, anyone in the field trying to sell Zetonna knows it.

So I say I hope the rumor that we are going to be sold of and no longer part of Sunovion is true, true, true.
Click to expand...

I don't know for sure if the respi division will be sold off or not. I have heard the same rumors. What puzzles me though is why Sunovion set up another company, Sunovion Respiratory Products. We did not need to do that just to absorb Elevation and its LAMA molecule. There isn't a Sunovion Oncology Products set up and we bought Boston Biomedical and their two molecules a year before that. Sunovion is a small, (and so is DSP) chickenshit company in the grand scheme of things. The two combined are a $4 billion organization--not all that large. The Pfizers, Mercks, Sanofis, even the Takedas and Forests of the world are much larger. Some could buy us cash without breaking a sweat. Why make this second corporation? It sure would be easy to sell off in one nice, neat little package, wouldn't it? I remember the presentation to investors a year ago, and it is still on the DSP website, where the future listed oncology and CNS as our future, and there was no mention of respiratory. I am still looking for the presentation to investors held a couple of weeks ago, but I can't find it.
Remember, this company was bought for one reason and one reason only--launch Latuda in the USA. I don't think the Japs give a real rat's ass for any of the existing products the company had, and are willing to sacrifice them all to make Latuda a successful, and very profitable, drug in the short window before it goes generic.
 












These quotas had to be set with the sole purpose of continuing our massive slide. Most Regions had about 10 to 15% of reps over 100% last Quarter...That will seem like the glory days compared to what is ahead. Once the scorecards start flying for Q1...shit will hit the fan...We've all seen this movie before...Threats, PIPS, etc....This place is so predictable and lame...We need real leadership and maybe a few account directors that can get us coverage...not more ridiculous "marketing" resources and programs...Seems as though we are being set up for disaster.
 






My RBM more or less told us to put the brakes on for Q1 since we don't even have a prayer. We will then hopefully get some relief in our Q2 quotas based on Q1 performance and for when the season actually comes. And if not, we are all screwed anyway.
 






What a winning strategy! I bet if you put the brakes on, stop selling and stop sampling, your sales will climb. Stay home, sales go up. If you want to put the brakes on, you should beg for scripts

Anonymous said:
My RBM more or less told us to put the brakes on for Q1 since we don't even have a prayer. We will then hopefully get some relief in our Q2 quotas based on Q1 performance and for when the season actually comes. And if not, we are all screwed anyway.
Click to expand...
 






Anonymous said:
I don't know for sure if the respi division will be sold off or not. I have heard the same rumors. What puzzles me though is why Sunovion set up another company, Sunovion Respiratory Products. We did not need to do that just to absorb Elevation and its LAMA molecule. There isn't a Sunovion Oncology Products set up and we bought Boston Biomedical and their two molecules a year before that. Sunovion is a small, (and so is DSP) chickenshit company in the grand scheme of things. The two combined are a $4 billion organization--not all that large. The Pfizers, Mercks, Sanofis, even the Takedas and Forests of the world are much larger. Some could buy us cash without breaking a sweat. Why make this second corporation? It sure would be easy to sell off in one nice, neat little package, wouldn't it? I remember the presentation to investors a year ago, and it is still on the DSP website, where the future listed oncology and CNS as our future, and there was no mention of respiratory. I am still looking for the presentation to investors held a couple of weeks ago, but I can't find it.
Remember, this company was bought for one reason and one reason only--launch Latuda in the USA. I don't think the Japs give a real rat's ass for any of the existing products the company had, and are willing to sacrifice them all to make Latuda a successful, and very profitable, drug in the short window before it goes generic.
Click to expand...

We liscense the products from Nicomed. Nicomed was recently purchased by Takeda. Takeda in the USA needs products. If Nicomed doesn't renew or renegotiate the liscensing agreeement with Sunovion they could just have Takeda which owns Niicomed promote the products iin the USA and they would have a much easier time promoting and contracting it as it will not be a liscensed product.

I hope we go to Takeda or some other company. Zetonna is IMPOSSIBLE to sell. Screw coverage - THE DOCTORS DON'T WANT IT. I could give any of my docs 5 solid years of samples for 100 patients and they still won't use it. This class is done. Its over. Why in the hell did we come out with this product? Someone please tell me. WHY????
 






Top Bottom
Back
Quote